These SMIs showed promising results in in vitro and in vivo experiments 5,8,25, with up to 80% reduction of ASPH enzymatic activity and a substantial decrease of proliferation, migration, and invasion of tumor cells in different cancer models 4,5. The gene discussed is ASPH; the disease is neoplasm.